Terumo Corporation (4543.T)
Chart Events
Performance Outlook
| Previous Close | 3,524.00 |
| Open | 3,566.00 |
| Bid | 3,605.00 x 0 |
| Ask | 3,611.00 x 0 |
| Day's Range | 3,558.00 - 3,619.00 |
| 52 Week Range | 3,471.00 - 4,744.00 |
| Volume | |
| Avg. Volume | 1,950,844 |
| Market Cap | 2.65T |
| Beta (5Y Monthly) | 0.48 |
| PE Ratio (TTM) | 31.14 |
| EPS (TTM) | 115.94 |
| Earnings Date | May 10, 2023 - May 15, 2023 |
| Forward Dividend & Yield | 42.00 (1.19%) |
| Ex-Dividend Date | Mar 30, 2023 |
| 1y Target Est | 4,910.70 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for 4543.T
Related Research
- PR Newswire
Terumo Prospective Registry Reinforces Safety, Efficacy and Efficiency of Radial Access in Visceral Interventions (R.A.V.I.) in Embolization Procedures
Terumo Medical Corporation (TMC) is pleased to announce the final results of its study demonstrating the safety and efficacy of Radial Access in Visceral Interventions (R.A.V.I.) in standard embolization procedures for uterine fibroids, benign prostatic hyperplasia, as well as liver and other hypervascular tumors. The findings were presented on March 7 at the Society of Interventional Radiology (SIR) 2023 Annual Scientific Meeting in Phoenix, AZ. SIR's annual scientific meeting is the largest pr
- Insider Monkey
15 Most Creative Companies In The World
In this piece, we will take a look at the fifteen most creative companies in the world. For more companies, head on over to 5 Most Creative Companies In The World. While creativity is generally thought to lie in the domain of the arts, it plays a central role in the business world as well. […]
- PR Newswire
New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography
A new study published in JAMA[1] demonstrated that patients at high risk for acute kidney injury (AKI), the most common complication of percutaneous coronary intervention (PCI), had a significant reduction in AKI when cardiologists used Terumo Health Outcomes' (THO's) ePRISM clinical decision support (CDS) platform.
